SBLATTERO, DANIELE
 Distribuzione geografica
Continente #
EU - Europa 1.990
NA - Nord America 1.712
AS - Asia 432
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 2
Totale 4.142
Nazione #
US - Stati Uniti d'America 1.698
IE - Irlanda 715
SE - Svezia 342
DE - Germania 311
UA - Ucraina 260
CN - Cina 183
FI - Finlandia 170
IT - Italia 136
SG - Singapore 96
HK - Hong Kong 76
IN - India 39
GB - Regno Unito 26
IR - Iran 16
BE - Belgio 14
CA - Canada 12
TR - Turchia 9
VN - Vietnam 9
EU - Europa 6
CZ - Repubblica Ceca 4
FR - Francia 3
RU - Federazione Russa 3
IL - Israele 2
MX - Messico 2
RO - Romania 2
BD - Bangladesh 1
CL - Cile 1
EC - Ecuador 1
GR - Grecia 1
LK - Sri Lanka 1
LT - Lituania 1
NL - Olanda 1
NO - Norvegia 1
Totale 4.142
Città #
Dublin 708
Jacksonville 483
Dearborn 219
Wilmington 125
Chandler 106
Lawrence 88
Princeton 88
Beijing 84
Ann Arbor 80
Hong Kong 76
San Mateo 75
Andover 58
Singapore 56
Piemonte 53
Düsseldorf 31
Ashburn 20
Boardman 17
Kunming 17
Hefei 15
Brussels 14
Monmouth Junction 14
Nanjing 13
Woodbridge 11
Helsinki 9
Kocaeli 9
Norwalk 9
Toronto 9
Bremen 8
Dong Ket 8
Fairfield 7
Philadelphia 7
Ardabil 6
Fuzhou 6
Grafing 6
Guangzhou 6
Houston 6
Jinan 6
Leawood 6
Nanchang 6
Seattle 6
Shenyang 6
Vercelli 6
Zanjan 6
Milan 5
Munich 5
Trieste 5
Turin 5
Brno 4
Dallas 4
Novara 4
Augusta 3
Redmond 3
Sacramento 3
Santa Clara 3
Chaoyang 2
Chengdu 2
Chongqing 2
Des Moines 2
Henderson 2
Horia 2
Kashan 2
London 2
Menlo Park 2
Scuola 2
Seregno 2
Torino 2
Wuhan 2
Amsterdam 1
Bangalore 1
Bolzaneto 1
Cambridge 1
Cividale Del Friuli 1
Colombo 1
Easley 1
Eboli 1
Frankfurt am Main 1
Fremont 1
Huzhou 1
Kemerovo 1
Los Angeles 1
Malgrate 1
Mexico 1
Mexico City 1
Minneapolis 1
Mumbai 1
Mülheim 1
Nanning 1
Nuremberg 1
Oggiono 1
Oslo 1
Ottawa 1
Portland 1
Quarto D'asti 1
Quito 1
Rome 1
Shanghai 1
Shaoxing 1
Taiyuan 1
Taizhou 1
Tappahannock 1
Totale 2.692
Nome #
RECOMBINANT ANTIBODIES AGAINST HUMAN TYPE II TRANSGLUTAMINASE AND USES THEREOF 99
ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo 99
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis 81
A reliable screening procedure for coeliac disease in clinical practice 80
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 80
Engineering mammalian cell factories with SINEUP noncoding RNAs to improve translation of secreted proteins 77
A definitive set of oligonucleotide primers for amplifying human V regions 76
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 74
Disruption of anthrax toxin binding with the use of human antibodies and competitive inhibitors 68
An Air-well sparging minifermenter system for high-throughput protein production. 68
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ 64
High-throughput assessment of the antibody profile in ovarian cancer ascitic fluids 63
SINEUPs are modular antisense long non-coding RNAs that increase synthesis of target proteins in cells 61
InteractomeSeq: a web server for the identification and profiling of domains and epitopes from phage display and next generation sequencing data 61
The RNA-binding protein ILF3 binds to transposable element sequences in SINEUP lncRNAs 60
Antibody library selection by the beta-lactamase protein fragment complementation assay 59
SINEUPs: A new class of natural and synthetic antisense long non-coding RNAs that activate translation 59
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives 57
Recombinant antibodies against CD55 and CD59 and uses thereof 57
Recombinant antibodies against CD55 and CD59 and uses thereof 57
Identification of novel proteins binding the AU-rich element of α-prothymosin mRNA through the selection of open reading frames (RIDome) 55
Treatment of arthritis models by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 54
A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome. 53
Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis 53
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 51
Antibodies in proteomics I: generating antibodies 51
Primer sets for cloning the human repertoire of T cell Receptor Variable regions 51
N-glycosylation of the mammalian dipeptidyl aminopeptidase-like protein 10 (DPP10) regulates trafficking and interaction with Kv4 channels 51
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects 51
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 51
Phage display technology for human monoclonal antibodies 49
Dpp10 - A New Putative Regulatory ß-subunit Of Ito In Failing And Non-failing Human Heart 49
Antibody library selection by the {beta}-lactamase protein fragment complementation assay 49
Deglycosylation effects of tunicamycin and neuraminidase on Kv4.3 channel complex 49
Anti-transglutaminase antibodies and age 48
Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of I (to) channel complex 48
Exploiting recombination in single bacteria to make large phage antibody libraries 46
Anti transglutaminase antibodies cause ataxia in mice 46
Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063 46
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 45
Binders based on dimerised immunoglobulin VH domains 44
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 44
Autoantibodies as predictors of disease 43
Method for the preparation by in vivo recombination of nucleic acid and polypeptide libraries and uses thereof 43
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis 43
Predicting antigenic peptides suitable for the selection of phage antibodies 43
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease 42
Profiling celiac disease antibody repertoire. 42
An albumin-derived peptide scaffold capable of binding and catalysis. 42
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 41
Anti-idiotypic response in mice expressing human autoantibodies 41
Testing for anti-human transglutaminase antibodies in saliva is not useful for diagnosis of celiac disease 40
Characterizing monoclonal antibody epitopes by filtered gene fragment phage display 40
The transmembrane beta-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current Ito 40
Filtering "genic" open reading frames from genomic DNA samples for advanced annotation 40
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 39
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 39
Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies 39
Profiling the autoantibody repertoire by screening phage-displayed human cDNA libraries 39
Rapid interactome profiling by massive sequencing 39
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 38
Characterization of the Anti-Tissue Transglutaminase Antibody Response in Nonobese Diabetic Mice 38
Mass screening for coeliac disease using antihuman transglutaminase antibody assay 38
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies 38
A deep-blue OLED-based biochip for protein microarray fluorescence detection. 38
Simple scale-up of recombinant antibody production using an UCOE containing vector 38
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease 36
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor 36
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells. 36
Plasmid incompatibility: more compatible than previously thought? 35
The gut as site of production of autoimmune antibodies 35
Development of a novel rapid non-invasive screening test for coeliac disease 34
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5. 34
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 34
Selecting open reading frames from DNA 33
Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet. 33
Dual sugar gut-permeability testing on blood drop in animal models 33
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics. 33
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine 32
Selection and characterization of a novel agonistic human recombinant anti-TRAIL_R2 minibody with anti_leukemic activity 32
Using archaeal histones for precise DNA fragmentation 32
Cryptic gluten intolerance in type 1 diabetes: identifying suitable candidates for a gluten free diet 31
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. 31
Mucosal tissue transglutaminase expression in celiac disease 31
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 30
Role of the C-terminal fragment of osteopontin in multiple sclerosis 30
Gluten ataxia: passive transfer in a mouse model 28
Defining the Helicobacter pylori Disease-Specific Antigenic Repertoire 22
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering 21
Totale 4.179
Categoria #
all - tutte 26.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.187


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020649 0 0 0 0 0 134 199 41 100 70 103 2
2020/2021597 90 0 85 14 59 16 91 14 93 19 97 19
2021/2022625 38 16 108 79 33 2 65 17 44 40 66 117
2022/20231.227 94 44 68 28 43 111 22 66 699 3 31 18
2023/2024298 29 14 22 8 61 5 72 5 0 1 24 57
2024/202574 10 3 28 6 18 9 0 0 0 0 0 0
Totale 4.179